Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Shanghai Junshi Biosciences Co., Ltd. has announced the election of Mr. Li Zhongxian and Ms. Lu Kun as independent non-executive directors, effective December 20, 2024. Both appointments were approved during the Extraordinary General Meeting, with each director set to receive an annual fee of RMB200,000. These changes are part of a strategic shift in the company’s audit and strategic committees.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.